Tumor-associated macrophages shape cancer’s immunosuppressive microenvironment, but their heterogeneity hampers therapeutic targeting. This study identifies a CD19+ macrophage subset in hepatocellular carcinoma and evaluates strategies to target them for improved immunotherapy.
- Junli Wang
- Wanyue Cao
- Qi Zhang